Characterization of Human Influenza Virus Variants Selected in Vitro in the Presence of the Neuraminidase Inhibitor GS 4071

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.42.12.3234
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

In Vivo Influenza Virus-Inhibitory Effects of the Cyclopentane Neuraminidase Inhibitor RWJ-270201

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2001English

Antibody Against Influenza A2 Virus Neuraminidase in Human Sera

Journal of Hygiene
1969English

Frequency of Naturally Occurring Antibody to Influenza Virus Antigenic Variants Selected in Vitro With Monoclonal Antibody

Journal of Hygiene
1981English

Influenza a Virus Neuraminidase

Science-Business eXchange
2010English

Characterization of Resistance to the Protease Inhibitor GS-9451 in Hepatitis C Virus-Infected Patients

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2012English

Peramivir Susceptibilities of Recombinant Influenza a and B Variants Selected With Various Neuraminidase Inhibitors

Antiviral Therapy
Infectious DiseasesPharmacology
2017English

The Impact of the Butterfly Effect on Human Parainfluenza Virus Haemagglutinin-Neuraminidase Inhibitor Design

Scientific Reports
Multidisciplinary
2017English

Influenza a Virus Neuraminidase (NA)

Science-Business eXchange
2011English

Antibody Response in Man to Influenza Virus Neuraminidase Following Influenza.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1968English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy